WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $478,000

Rhea-AI Summary

Healthcare Triangle (Nasdaq: HCTI) entered into warrant exercise agreements with certain accredited and institutional investors to immediately exercise an aggregate of 239,051 existing warrants for gross cash proceeds of approximately $478,000. The company agreed to reduce the existing warrant exercise price from $20.92 to $2.00 per share.

In a private placement, the exercising holders will receive new unregistered warrants to purchase up to 239,051 shares at an exercise price of $3.00 per share; the New Warrants are immediately exercisable and expire five years from issuance. The transactions and closing are expected on or about October 8, 2025. WallachBeth Capital acted as financial advisor.

Positive

• Immediate cash inflow of approximately $478,000
• 239,051 warrants converted to new, exercisable instruments
• New warrants exercisable immediately with 5-year term

Negative

• Existing warrant exercise price reduced from $20.92 to $2.00
• Potential future dilution from 239,051 new-warrant shares at $3.00
• Gross proceeds exclude advisor fees and other transaction expenses

Insights

Capital Markets Strategist

Warrant inducement nets $478,000, creates deeply discounted strikes and adds potential dilution.

The company agreed to have holders immediately exercise 239,051 existing warrants for gross cash proceeds of $478,000 and concurrently issued new unregistered warrants to buy an equal number of shares at an exercise price of $3.00. It also reduced the exercise price of the Existing Warrants from $20.92 to $2.00, and the New Warrants expire five years from issuance with immediate exercisability on October 8, 2025.

This raises near-term cash but at a material concession to warrant holders: the $2.00 reset and the $3.00 new strike substantially lower the future share conversion price, increasing dilution risk if warrants are exercised. The deal size ($478,000) is modest relative to typical operating needs, so its ability to change fundamentals depends on undisclosed cash burn or uses.

Watch the closing on or about October 8, 2025, any fees that reduce net proceeds, and whether holders exercise the New Warrants — these determine actual dilution and funding impact over the next five years.

JERSEY CITY, N.J., Oct. 8, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced it has entered into warrant exercise agreements with certain existing accredited and institutional investors to exercise outstanding warrants to purchase an aggregate of 239,051 of the Company's shares of common stock (the "Existing Warrants"). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of approximately $478,000, the exercising holders will receive in a private placement new unregistered warrants (the "New Warrants") to purchase up to an aggregate of 239,051 shares of common stock (equal to 100% of the shares of common stock issued in connection with the exercise of the Existing Warrants) with an exercise price of $3.00 per share. The New Warrants are immediately exercisable on the date of issuance and will expire five years from the date of issuance. In connection with the exercise of the Existing Warrants, the Company agreed to reduce the exercise price of the Existing Warrants from $20.92 to $2.00 per share. The exercise of the Existing Warrants and the issuance of the New Warrants are expected to occur on October 8, 2025.

The closing of the offering is expected to occur on or about October 8, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the warrant inducement are expected to be approximately $478,000, excluding any proceeds that may be received upon the exercise of the New Warrants and before deducting financial advisor fees and other expenses payable by the Company.

WallachBeth Capital is acting as financial advisor for the warrant inducement transaction.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

About WallachBeth Capital LLC

WallachBeth Capital LLC is a broker-dealer providing advisory and execution services in capital markets transactions for corporate clients. The firm's investment-banking activities include initial public offerings, follow-on offerings, private placements, PIPE transactions, and at-the-market (ATM) programs. WallachBeth Capital LLC is a member of FINRA and SIPC.

Forward-Looking Statements and Safe Harbor Notice:

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which Healthcare Triangle, Inc. operates, as well as management's beliefs and assumptions. Forward-looking statements include, but are not limited to, statements regarding revenue growth, margin expansion, market opportunities, and strategic initiatives. These statements involve risks, uncertainties, and assumptions that are difficult to predict. Actual outcomes may differ materially from those expressed or implied in any forward-looking statements due to various factors beyond the company's control, including changes in market conditions, client demand, regulatory developments, and execution risks. Readers are cautioned not to place undue reliance on these forward-looking statements. Healthcare Triangle, Inc. undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

The above statement is made solely by Healthcare Triangle, Inc. WallachBeth Capital LLC is not responsible for these statements and does not provide research, analysis, or recommendations regarding HCTI securities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/wallachbeth-capital-announces-healthcare-triangle-warrant-inducement-for-aggregate-gross-proceeds-of-478-000--302578972.html

SOURCE WallachBeth Capital LLC

FAQ

What did Healthcare Triangle (HCTI) announce on October 8, 2025?

HCTI announced exercise of 239,051 existing warrants for approx. $478,000 and issuance of equal-number new warrants.

How was the exercise price changed for HCTI existing warrants?

The company reduced the existing warrant exercise price from $20.92 to $2.00 per share.

What are the terms of the new warrants issued to HCTI holders?

New unregistered warrants cover 239,051 shares, exercisable at $3.00 per share and expire in 5 years.

When is the HCTI warrant inducement transaction expected to close?

The exercise and issuance are expected to occur on or about October 8, 2025, subject to closing conditions.

How much cash will HCTI receive from the warrant inducement?

Gross cash proceeds are expected to be approximately $478,000, before fees and expenses.

Who advised Healthcare Triangle on the warrant inducement?

WallachBeth Capital acted as the financial advisor for the warrant inducement transaction.